COLL
COLLEGIUM PHARMACEUTICAL, INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$22.77
+1.74%Forward multiples
Based on analyst estimates
- P/E forward
- 3.29x
- P/E 2026E
- 3.02x
- P/E 2027E
- 3.37x
- P/E 2028E
- 3.52x
- P/S forward
- 0.82x
Trailing multiples
Trailing twelve months
- P/E TTM
- 14.88x
- PEG TTM
- 0.04x
- Price / book
- 2.26x
- Price / sales
- 0.87x
- Price / cash flow
- 2.14x
Enterprise value
- Enterprise value
- $1.4B
- EV / sales
- 1.77x
- EV / EBITDA
- 2.45x
- EV / EBIT
- 9.05x
- Market cap
- $705.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026